Francisco Partners said Sept. 5 that it closed the sale of Therapeutic Research Center to Levine Leichtman Capital Partners. Financial terms weren’t announced. TRC, of Stockton, California, provides medication advisory and learning solutions for pharmacists, pharmacy technicians, prescribers, nurses and other clinicians. William Blair & Company served as financial adviser and Paul Hastings LLP acted as the attorney to TRC. September 5, 2017 – SAN FRANCISCO — Francisco Partners (FP), a leading technology-focused private equity firm, today reported the successful closing of the sale of Therapeutic Research Center (TRC) to Levine Leichtman Capital Partners (LLCP).